Whether you have an ad-hoc experiment or multiple preclinical studies in the pipeline, our team has the experience and a proven process to get you to your next milestone.
We work with biotech companies, academic startups and venture firms developing preclinical assets ranging from drug discovery, lead candidate selection, lead optimization and IND enabling studies.
We specialize in oncology, immunology, neuro/CNS, respiratory, metabolic and infectious diseases, across different modalities.
Radyus works with biotech companies, life science accelerators, venture funds, and academic spinouts on a path to IND.
See how we've helped our clients move their therapeutics forward.
Plug into our 150 years of drug development expertise.
Not sure where to start, what it costs, or what experiment to do next? Schedule a complementary 20-minute call with our CEO, Dr. Marta New.